)
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
Sohini Das writes on automobile and healthcare sectors for Business Standard. Over her 17 years as a journalist, she has covered multiple sectors and issues -- FMCG, dairy, tourism, and state elections, among others, across Kolkata, Ahmedabad, and Mumbai. She loves doing personality stories and ground reportage.
JSW MG Motor India says its new multi-powertrain ADAPT platform will underpin future new energy vehicles, with an electric SUV and a plug-in hybrid SUV slated for launch during FY27
Trend leads to more women being employed on vehicle assembly lines
Draft norms propose tighter fuel-efficiency targets from FY28 to FY32, compliance credits, super credits for cleaner vehicles and incentives for renewable fuels
The agreement positions the Pune-based vaccine maker to manufacture the M72/AS01E TB vaccine candidate at scale if ongoing Phase III trials succeed and approvals are secured
Tata Motors has urged the Centre to revise draft CAFE norms, saying the proposed credit mechanism could make non-compliance cheaper than cleaner technology investments
NATHEALTH president also pitches prevention-led insurance, PPPs and a national mission to scale medical value travel
Fada data shows legacy players driving nearly all first-half market growth, while Ather remains the standout among EV-first manufacturers
Restructuring positions biotech arm to focus on biologics and biosimilar
BEML is ramping up R&D to develop indigenous technologies across rail, defence and mobility, targeting 35-40 new products and stronger aerospace capabilities
While expanded traceability aims to curb counterfeit medicines, industry says predictive manufacturing could help reduce NSQ drugs
Industry says amendments reduce procedural burden while tightening documentation and record-keeping norms for drug manufacturers under the pricing order
Strong overseas demand and easing shipping disruptions sustain export momentum
Q1 Vahan data show overall PV market share rising to 14.2% from 12.5%, reinforcing Tata Motors' No. 2 position
Indian companies filed 184 Type II DMFs with the US FDA in Q1 2026 against China's 149, reinforcing the country's leadership in API manufacturing and future generic drug development
The antitrust watchdog rejected its Director General's findings, ruling there was no evidence of anti-competitive agreements involving stockist appointments or new drug launches
Fresh registrations to stop over the next 2 years under new EV policy
Digital platforms, international operations and mobility services are emerging as key growth drivers as Tata Motors Commercial Vehicles seeks to reduce cyclicality
India's southwest monsoon from June 1 to June 23 has been almost 43% below normal, among its worst performances in the last several years
HRV Pharma owns drug master files and customer relationships while outsourcing production to 53 manufacturing partners, aiming to scale without owning factories
JLR says local manufacturing plans remain unchanged as India opens its premium vehicle market to British imports while protecting lower-cost EV segments